pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 28·1 min read
save

Anthony Fauci scheduled to testify before Senate Homeland Security Committee

Jul 28, 2026·read at STAT ↗RegulatoryNeutral

Anthony Fauci has been subpoenaed to appear before the Senate Homeland Security Committee for a new testimony. The hearing is scheduled for tomorrow and will focus on issues related to the federal response to the COVID-19 pandemic.

This appearance follows earlier testimonies by Fauci before other congressional panels, reflecting continued legislative interest in the handling of the health crisis.

The report was published in STAT’s D.C. Diagnosis newsletter, which covers health policy and politics. Access to the full article requires a STAT+ subscription.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Bracing for another Fauci hearing”

read at STAT ↗
423 words · retrieved Jul 28
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
Rare Disease

related stories

  • May 12STAT+: Hims’ sales miss as telehealth competition growsSTAT
  • May 12STAT+: Capsida says it still doesn’t know what caused gene therapy deathSTAT
  • May 12A year after Vertex’s big launch, pain drug research faces a pivotal momentBioPharma Dive
  • May 11No FDA permission, no problem: New flavored vape policy worries expertsSTAT
  • May 11STAT+: Astellas treatment offers new hope to a devastated rare disease communitySTAT